A 69-year-old womanwith idiopathic thrombocytopenic purpura, who was regularly followed and treated with prednisolone and danazol, was admitted to our hospital because of shortness of breath. Chest roentgenogram showed a large amount of left-sided pleural effusion. Gram-positive branching rods, subsequently identified as Nocardia farcinica, were isolated from the fluid. Antibiotic treatment together with pleural drainage with an intercostal catheter resulted in complete remission of pyothorax. Pulmonary nocardiosis is a rare disease, but recognition of the disease in immunocompromised patients and the prompt initiation of appropriate treatments based on isolation of the pathogen can lead to a successful outcome. (Internal Medicine 40: 246-249, 2001) 
Introduction
Nocardia species are aerobic actinomycetes commonly found in the soil. Previous studies (1) have shown that nocardiosis occurs predominantly in immunocompromisedpatients such as those with hematological malignancies, those with collagen vascular diseases, and recipients of organ transplant, and that it sometimes causes a lethal outcome in these patients.
The commonsite of the infection is the lung, although clinical manifestations are quite variable in each patient ranging from an insidious onset to an acute one resembling pulmonaryinfarction (2) . Here, we report a patient with pulmonary nocardiosis, which was manifested by pyothorax during the followup period of idiopathic thrombocytopenic purpura (ITP) and successfully treated with imipenem/cilastacin (IPM/CS).
Case Report
A 69-year-old womanwas diagnosed to have ITP based on purpuric spots, thrombocytopenia, increased megakaryocyte in her bone marrow, and positivity for platelet associated immunoglobulin in 1987. Prednisolone, azathioprine, anabolic steroid, high dose of intravenous gamma-immunoglobulin, and splenectomy had failed to improve her thrombocytopenia and the platelet count remained at about 10 to 30x1OV^l. In June 1999, she complained of increased leg purpuric spots. Her platelet count dropped to 8x103/jll1 in spite of 10 mg/day of oral prednisolone and 200 mg/day of danazol. Then the dose of steroids was doubled. Thereafter her platelet count increased to around 20xl03/(il.
On her visit at the end of September 1999, her platelet count rose to 126xlO3/jil, but we could not find any cause for this increase on physical examination or with her normal white blood cell (WBC) count. Two weeks later, she presented with shortness of breath and loss of appetite. The results of her physical examination were unremarkableexcept for a few rales at the left lung base. Her WBCcount was 18.4xlO3/|il with marked neutrophilia (9 1 %) and platelet count 160xl03/|il. Biochemical analysis was unremarkable. C-reactive protein was 24.7 mg/ dl. Fasting plasma glucose and hemoglobin A,c were 146 mg/ dl and 6.8%, respectively. Chest roentgenogram revealed consolidate-like shadow in the left mid-lower lung field and massive left-sided pleural effusion (Fig. 1A) . Chest CT showed the presence of the fluid encapsulated by irregularly thickened pleural membrane (Fig. IB) . Because of the prolonged use of steroids without prophylaxis, we suspected tuberculous pleuritis at the time of admission. She was treated with antituberculous agents and intravenous imipenem/cilastacin (IPM/CS) for concomitant bacterial infections. A therapeutic thoracentesis was performed, and Gram-positive branching rods, subsequently identified as Nocardia farcinica with biochemical methods, were found in the pleural fluid ( Breathing became easy and her appetite gradually recovered. Abnormal chest X-ray findings disappeared almost completely after two weeks of the therapy and the increased platelet count also gradually returned to the previous levels, between 20 and 30xl03/|il. As subsequent maintenance therapy, 100 mg/ day of minocycline followed IPM/CS due to severe skin rash from trimethoprim-sulfamethoxazole (TMP-SMX). To avoid relapse or recurrence of nocardiosis, she was advised to continue oral minocycline for at least one year. As it was reasonable to consider that long-term corticosteroid therapy had made this patient susceptible to nocardiosis, weevaluated whether her T-lymphocyteswere competent, as glucocorticoids are known to impair T cell responses. Although the numberof each T-lymphocytesubset was not decreased according to surface markers, the response to conacanavalin A and phytohemagglutinin was moderately attenuated (Table 1 ) . Relative thrombocytosis, seen before and shortly after her symptomsand signs developed, was thought reactive to nocardial infection. It is knownthrombopoietic cytokines contribute at least partially to this phenomenon (3, 4) . To evaluate if this was the case, we measured the serum level of two potent thrombopoietic cytokines, thrombopoietin (TPO) and interleukin 6 (IL-6), at admission and near recovery. As shown in Table 2 , both cytokines were elevated in association with The presentation is quite variable ranging from an insidious onset to an acute presentation similar to that of pulmonary infarction (5) . The diagnosis should be based on isolation of Nocardia spp., but it is often difficult to identify in sputum cultures. If nocardiosis is suspected clinically, invasive diagnostic techniques, such as transbronchial biopsy, percutaneous lung aspiration, needle biopsy and open lung biopsy, must be performed (6, 7) if possible. The mainstay of therapy has been sulfonamides, and TMP-SMX has been clinically effective as well. Amikacin, imipenem, ceftriaxone, cefotaxime, and fluoroquinolones are drugs of choice as well (1).
The most commonpathogen of pulmonary nocardiosis is N asteroides, which has been shownto be a heterogeneous group of organisms, which are subdivided into several subtypes based on biochemical properties and antibiotic susceptibility patterns, N. asteroides sensu stricto, N. farcinica, N nova, and others (1, 8) . N farcinica is less frequently seen, but is knownto be more resistant to antibiotics (9) and virulent than N. asteroides (10) . Catalase activity against oxygen burst of phagocytic cells, secreted superoxide dismutase, and cell wall contents are believed to be associated with virulence (8), but what determines the difference of virulence amongthose subtypes is not fully understood. In this case report, we illustrated pulmonary nocardiosis associated with idiopathic thrombocytopenic purpura (ITP). It is difficult to isolate the pathogen since only less than 30%of pulmonary nocardiosis is diagnosed with the result of sputum cultures (1 1). In the present case we could successfully isolate the pathogen in the pleural fluid. As mentioned above, we emphasize the importanceof invasive maneuversto reach the correct diagnosis in pulmonary nocardiosis. It is widely accepted that the first line of antimicrobial agents against Nocardia spp. is sulfonamideor TMP-SMX. But wecontinued the therapy unchanged after isolation of Nocardia because not only had her clinical course indicated effectiveness of IPM/CSbut also it has been reported that IPM/CSis effective for Nocardia in vivo (12) (13) (14) (15) . Although some antimicrobial agents including IPM/CShave shown in vitro inhibition of greater than 80%for N. Asteroides (15) , as far as we know, only Lo and Rolston (12) have reported a case of pulmonary nocardiosis that was successfully treated with IPM/CS alone. And some reports (6, 16) have shown fatal outcomes with empirical antibiotic regimens including imipenem. The factors that determine the difference between in vitro and in vivo susceptibilities of antibiotics are not clear. As in the case presented here, sulfonamide and TMP-SMX are knownto have commonadverse effects of bone marrow toxicity and skin rash, and thus the use of minocycline is recommended instead (14) . Wealso chose minocycline following IPM/CS and achieved successful treat- ment. It is noteworthy that delayed diagnosis and inappropriate therapy can result in lethal outcomes. Therefore, it is important to recognize the disease itself, especially in immunocompromised patients and prompt initiation of the appropriate treatment based on isolation of the pathogen is critical. Suppression of cell-mediated immuneresponse, particularly macrophagesand T cells, plays an important role to establish the nocardiosis (8) . Glucocorticoid is well recognized and widely used for immunesuppression, and one of the great risk factors for invasive nocardiosis. In the present case, both prolonged corticosteroid administration and the hyperglycemic state, which is occasionally seen as an adverse effect of steroids, were considered to be the major contributors to her impaired immunity (Table 1) . Reactive thrombocytosis, defined as a platelet level of greater than 440x l03/|Lil (4), is occasionally seen in infectious diseases, collagen vascular diseases, and malignancies. It seems to be caused at least in part by augmented thrombopoiesis under the influence of several cytokines (3, 4) as a result of an inflammatory process. Also it has been reported in nocardiosis (5, (17) (18) (19) , but no possible reason for thrombocytosis has been shown. Although the relative thrombocytosis seen here did not meet the criteria, it waseasy to consider that it was quite similar to the reactive one since she wassuffering from ITP, whichis characterized by augmented consumption of the platelet. As expected, the serum levels of TPO and IL-6, potent thrombopoietic cytokines, were elevated as shown in Table 2 . Therefore, we concludedthat these cytokines weremajor contributing factors in the thrombocytosis in this patient.
Conclusion
Wedescribed a case of pulmonary nocardiosis associated with ITP. Although it is rare, nocardiosis must be recognized, especially in immunocompromisedpatients. Prompt initiation of appropriate treatments based on isolation of the pathogen is important.
